{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:51:00Z","timestamp":1790016660818,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06367-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T17:09:54Z","timestamp":1763485794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integration of RASSF1A and TSPYL5 methylation and AFP protein as plasma biomarker for hepatocellular carcinoma diagnosis"],"prefix":"10.1007","volume":"151","author":[{"given":"Haiyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingmin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengke","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaogui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"6367_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V et al (2018) Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391:1023\u20131075","journal-title":"Lancet"},{"key":"6367_CR2","doi-asserted-by":"crossref","unstructured":"Alter MJ (1995) Epidemiology of hepatitis C in the West. In Seminars in liver disease. \u00a9 1995 by Thieme Medical Publishers, Inc., pp 5\u201314","DOI":"10.1055\/s-2007-1007259"},{"key":"6367_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153796","volume":"11","author":"OC Ara\u00fajo","year":"2016","unstructured":"Ara\u00fajo OC, Rosa AS, Fernandes A et al (2016) RASSF1A and DOK1 promoter methylation levels in hepatocellular carcinoma, cirrhotic and non-cirrhotic liver, and correlation with liver cancer in Brazilian patients. PLoS ONE 11:e0153796","journal-title":"PLoS ONE"},{"key":"6367_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3130","author":"SB Baylin","year":"2011","unstructured":"Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome \u2014 biological and translational implications. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc3130","journal-title":"Nat Rev Cancer"},{"key":"6367_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019505","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA (2016) Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a019505","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"6367_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE et al (2021) Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:541\u2013565","journal-title":"J Natl Compr Canc Netw"},{"key":"6367_CR7","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"6367_CR8","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","volume":"63","author":"J Bruix","year":"2014","unstructured":"Bruix J, Gores GJ, Mazzaferro V (2014) Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63:844\u2013855","journal-title":"Gut"},{"key":"6367_CR9","first-page":"59","volume":"6","author":"RL Brunsing","year":"2020","unstructured":"Brunsing RL, Fowler KJ, Yokoo T et al (2020) Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI. Hepatoma Res 6:59","journal-title":"Hepatoma Res"},{"key":"6367_CR10","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1172\/JCI31457","volume":"117","author":"DF Calvisi","year":"2007","unstructured":"Calvisi DF, Ladu S, Gorden A et al (2007) Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 117:2713\u20132722","journal-title":"J Clin Invest"},{"key":"6367_CR11","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.cgh.2020.08.065","volume":"19","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Ramasubramanian TS, Bhattacharya A et al (2021) A novel blood-based panel of methylated DNA and protein markers for detection of early-stage hepatocellular carcinoma. Clin Gastroenterol Hepatol 19:2597-2605.e2594","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6367_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cgh.2021.08.010","volume":"20","author":"NP Chalasani","year":"2022","unstructured":"Chalasani NP, Porter K, Bhattacharya A et al (2022) Validation of a novel multitarget blood test shows high sensitivity to detect early stage hepatocellular carcinoma. Clin Gastroenterol Hepatol 20:173-182.e177","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6367_CR13","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1373\/clinchem.2008.104653","volume":"54","author":"KC Chan","year":"2008","unstructured":"Chan KC, Lai PB, Mok TS et al (2008) Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem 54:1528\u20131536","journal-title":"Clin Chem"},{"key":"6367_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-015-0014-8","volume":"8","author":"A D\u00edez-Villanueva","year":"2015","unstructured":"D\u00edez-Villanueva A, Mallona I, Peinado MA (2015) Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer. Epigenetics Chromatin 8:1\u20138","journal-title":"Epigenetics Chromatin"},{"key":"6367_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13000-015-0317-x","volume":"10","author":"X Dong","year":"2015","unstructured":"Dong X, He H, Zhang W et al (2015a) Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. Diagn Pathol 10:133","journal-title":"Diagn Pathol"},{"key":"6367_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-015-0317-x","volume":"10","author":"X Dong","year":"2015","unstructured":"Dong X, He H, Zhang W et al (2015b) Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection. Diagn Pathol 10:1\u20137","journal-title":"Diagn Pathol"},{"key":"6367_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ncb2142","volume":"13","author":"MT Epping","year":"2011","unstructured":"Epping MT, Meijer LA, Krijgsman O et al (2011) TSPyl5 suppresses p53 levels and function by physical interaction with USP7. Nat Cell Biol 13:102\u2013108","journal-title":"Nat Cell Biol"},{"key":"6367_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.neo.2020.09.007","volume":"22","author":"X Fan","year":"2020","unstructured":"Fan X, Li Y, Yi X et al (2020) Epigenome-wide DNA methylation profiling of portal vein tumor thrombosis (PVTT) tissues in hepatocellular carcinoma patients. Neoplasia 22:630\u2013643","journal-title":"Neoplasia"},{"key":"6367_CR19","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3390\/cancers15194784","volume":"15","author":"S Fu","year":"2023","unstructured":"Fu S, Deger T, Boers RG et al (2023) Hypermethylation of DNA methylation markers in non-cirrhotic hepatocellular carcinoma. Cancers 15:4784","journal-title":"Cancers"},{"key":"6367_CR20","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/cancers14061384","volume":"14","author":"P Gilson","year":"2022","unstructured":"Gilson P, Merlin JL, Harle A (2022) Deciphering tumour heterogeneity: from tissue to liquid biopsy. Cancers (Basel) 14:1384","journal-title":"Cancers (Basel)"},{"key":"6367_CR21","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/bjc.2015.221","volume":"113","author":"AM Grawenda","year":"2015","unstructured":"Grawenda AM, O\u2019Neill E (2015) Clinical utility of RASSF1A methylation in human malignancies. Br J Cancer 113:372\u2013381","journal-title":"Br J Cancer"},{"key":"6367_CR22","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.3748\/wjg.v25.i13.1550","volume":"25","author":"PS Harris","year":"2019","unstructured":"Harris PS, Hansen RM, Gray ME et al (2019) Hepatocellular carcinoma surveillance: an evidence-based approach. World J Gastroenterol 25:1550\u20131559","journal-title":"World J Gastroenterol"},{"key":"6367_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.mrrev.2011.04.001","volume":"727","author":"Z Herceg","year":"2011","unstructured":"Herceg Z, Paliwal A (2011) Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat Res 727:55\u201361","journal-title":"Mutat Res"},{"key":"6367_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/hep.31659","volume":"74","author":"G Hernandez-Meza","year":"2021","unstructured":"Hernandez-Meza G, von Felden J, Gonzalez-Kozlova EE et al (2021) DNA methylation profiling of human hepatocarcinogenesis. Hepatology 74:183\u2013199","journal-title":"Hepatology"},{"key":"6367_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12072-010-9164-8","volume":"4","author":"L Hu","year":"2010","unstructured":"Hu L, Chen G, Yu H, Qiu X (2010) Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatol Int 4:423\u2013432","journal-title":"Hepatol Int"},{"key":"6367_CR26","doi-asserted-by":"publisher","first-page":"7490","DOI":"10.1158\/0008-5472.CAN-05-4552","volume":"66","author":"TY Kim","year":"2006","unstructured":"Kim TY, Zhong S, Fields CR et al (2006) Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 66:7490\u20137501","journal-title":"Cancer Res"},{"key":"6367_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/hep.30244","volume":"69","author":"JB Kisiel","year":"2019","unstructured":"Kisiel JB, Dukek BA, VSR Kanipakam R et al (2019) Hepatocellular carcinoma detection by plasma methylated DNA: discovery, phase I pilot, and phase II clinical validation. Hepatology 69:1180\u20131192","journal-title":"Hepatology"},{"key":"6367_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4149\/neo_2017_519","volume":"64","author":"ZJ Liu","year":"2017","unstructured":"Liu ZJ, Huang Y, Wei L et al (2017) Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection. Neoplasma 64:795\u2013802","journal-title":"Neoplasma"},{"key":"6367_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","volume":"20","author":"B Luo","year":"2022","unstructured":"Luo B, Ma F, Liu H et al (2022) Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med 20:8","journal-title":"BMC Med"},{"key":"6367_CR30","first-page":"1637","volume":"18","author":"LA Mansour","year":"2017","unstructured":"Mansour LA, El Raziky M, Mohamed AA et al (2017) Circulating Hypermethylated RASSF1A as a molecular biomarker for diagnosis of hepatocellular carcinoma. Asian Pac J Cancer Prev 18:1637\u20131643","journal-title":"Asian Pac J Cancer Prev"},{"key":"6367_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur V, Iljasenko T, Metsalu T et al (2018) Methsurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10:277\u2013288","journal-title":"Epigenomics"},{"key":"6367_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000343860","volume":"3","author":"N Nishida","year":"2014","unstructured":"Nishida N, Kudo M (2014) Alteration of epigenetic profile in human hepatocellular carcinoma and its clinical implications. Liver Cancer 3:417\u2013427","journal-title":"Liver Cancer"},{"key":"6367_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12029-017-9959-0","volume":"48","author":"A Ozakyol","year":"2017","unstructured":"Ozakyol A (2017) Global epidemiology of hepatocellular carcinoma (HCC epidemiology). J Gastrointest Cancer 48:238\u2013240","journal-title":"J Gastrointest Cancer"},{"key":"6367_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/CBM-181638","volume":"24","author":"HF Pasha","year":"2019","unstructured":"Pasha HF, Mohamed RH, Radwan MI (2019) RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma. Cancer Biomark 24:241\u2013247","journal-title":"Cancer Biomark"},{"key":"6367_CR35","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.2217\/fon-2022-1218","volume":"18","author":"TH Phan","year":"2022","unstructured":"Phan TH, Chi Nguyen VT, Thi Pham TT et al (2022) Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma. Future Oncol 18:4399\u20134413","journal-title":"Future Oncol"},{"key":"6367_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.canlet.2012.01.038","volume":"342","author":"IP Pogribny","year":"2014","unstructured":"Pogribny IP, Rusyn I (2014) Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett 342:223\u2013230","journal-title":"Cancer Lett"},{"key":"6367_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10620-015-3878-3","volume":"61","author":"X Qiu","year":"2016","unstructured":"Qiu X, Hu B, Huang Y et al (2016) Hypermethylation of ACP1, BMP4, and TSPYL5 in hepatocellular carcinoma and their potential clinical significance. Dig Dis Sci 61:149\u2013157","journal-title":"Dig Dis Sci"},{"key":"6367_CR38","first-page":"1677","volume":"11","author":"P Saelee","year":"2010","unstructured":"Saelee P, Wongkham S, Chariyalertsak S et al (2010) RASSF1A promoter hypermethylation as a prognostic marker for hepatocellular carcinoma. Asian Pac J Cancer Prev 11:1677\u20131681","journal-title":"Asian Pac J Cancer Prev"},{"key":"6367_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12920-015-0105-1","volume":"8","author":"J Shen","year":"2015","unstructured":"Shen J, LeFave C, Sirosh I et al (2015) Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas. BMC Med Genomics 8:28","journal-title":"BMC Med Genomics"},{"key":"6367_CR40","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1002\/hep4.2045","volume":"6","author":"AG Singal","year":"2022","unstructured":"Singal AG, Haaland B, Parikh ND et al (2022) Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: results of a network meta-analysis. Hepatol Commun 6:2925\u20132936","journal-title":"Hepatol Commun"},{"key":"6367_CR41","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1148\/rg.2016160042","volume":"36","author":"A Srinivasa Babu","year":"2016","unstructured":"Srinivasa Babu A, Wells ML, Teytelboym OM et al (2016) Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics 36:1987\u20132006","journal-title":"Radiographics"},{"key":"6367_CR42","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1245\/s10434-019-07580-9","volume":"26","author":"DI Tsilimigras","year":"2019","unstructured":"Tsilimigras DI, Bagante F, Sahara K et al (2019) Prognosis after resection of Barcelona Clinic Liver Cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol 26:3693\u20133700","journal-title":"Ann Surg Oncol"},{"key":"6367_CR43","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B (2018) Linkedomics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res 46:D956\u2013D963","journal-title":"Nucleic Acids Res"},{"key":"6367_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.31309","volume":"73","author":"E Wolf","year":"2021","unstructured":"Wolf E, Rich NE, Marrero JA et al (2021) Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis. Hepatology 73:713\u2013725","journal-title":"Hepatology"},{"key":"6367_CR45","volume":"2","author":"Q Wu","year":"2013","unstructured":"Wu Q, Qin SK (2013) Features and treatment options of Chinese hepatocellular carcinoma. Chin Clin Oncol 2:38","journal-title":"Chin Clin Oncol"},{"key":"6367_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12935-020-01638-5","volume":"20","author":"G Xu","year":"2020","unstructured":"Xu G, Zhou X, Xing J et al (2020) Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma. Cancer Cell Int 20:547","journal-title":"Cancer Cell Int"},{"key":"6367_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cgh.2010.09.017","volume":"9","author":"NC Yu","year":"2011","unstructured":"Yu NC, Chaudhari V, Raman SS et al (2011) CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 9:161\u2013167","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6367_CR48","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/1078-0432.CCR-06-1900","volume":"13","author":"Y-J Zhang","year":"2007","unstructured":"Zhang Y-J, Wu H-C, Shen J et al (2007a) Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res 13:2378\u20132384","journal-title":"Clin Cancer Res"},{"key":"6367_CR49","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1158\/1078-0432.CCR-06-2268","volume":"13","author":"C Zhang","year":"2007","unstructured":"Zhang C, Li Z, Cheng Y et al (2007b) Cpg island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Clin Cancer Res 13:944\u2013952","journal-title":"Clin Cancer Res"},{"key":"6367_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1158\/1055-9965.EPI-19-1052","volume":"29","author":"X Zhang","year":"2020","unstructured":"Zhang X, El-Serag HB, Thrift AP (2020) Sex and race disparities in the incidence of hepatocellular carcinoma in the United States examined through age\u2013period\u2013cohort analysis. Cancer Epidemiol Biomarkers Prev 29:88\u201394","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6367_CR51","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1868-7083-6-30","volume":"6","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Xue F, Sun J et al (2014) Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma. Clin Epigenetics 6:30","journal-title":"Clin Epigenetics"},{"key":"6367_CR52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","volume":"12","author":"J Zhou","year":"2023","unstructured":"Zhou J, Sun H, Wang Z et al (2023) Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition). Liver Cancer 12:405\u2013444","journal-title":"Liver Cancer"},{"key":"6367_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5009\/gnl15257","volume":"10","author":"RX Zhu","year":"2016","unstructured":"Zhu RX, Seto W-K, Lai C-L, Yuen M-F (2016) Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver 10:332","journal-title":"Gut Liver"},{"key":"6367_CR54","doi-asserted-by":"crossref","unstructured":"Zocchi ML, Vindigni V (2022) Ultrasonic-assisted lipoplasty. Atlas of whole body contouring: a practical guide, pp 203\u2013236","DOI":"10.1007\/978-3-030-94755-2_16"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06367-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T21:02:02Z","timestamp":1765659722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06367-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6367"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06367-8","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Linhong Li and Xiaomo Li are employees of Oriomics Biotech Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of The Affiliated Fifth People\u2019s Hospital of Ganzhou.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study participants gave written informed consent before sample collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"324"}}